Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mankind Pharma

Explore full profile

Quality pharmaceutical formulations and consumer healthcare products at affordable prices

New Delhi, IndiaFounded 1991Biotech & Life Sciences
Valuation $14B Market cap · Aug/2026
Revenue $1.94B Latest reported FY
EBITDA $542M Latest reported FY

At a glance

Founded
1991
Headquarters
New Delhi, India
Listing
IPO 2023
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Chrys Capital

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
24 countries with
team presence
🇮🇳 India98.6%
🇳🇵 Nepal0.3%
🇦🇪 United Arab Emirates0.2%
🇺🇸 United States0.2%
🇱🇰 Sri Lanka0.1%
Top 5 of 24 shown
Web traffic by country
61K monthly visits
across markets
🇮🇳 India86.4%
🇺🇸 United States6.1%
🇬🇧 United Kingdom2.6%
🇨🇦 Canada1.6%
🇦🇪 United Arab Emirates1.3%
Top 5 markets shown

Patents

Estimated portfolio value
$23M

130 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Mankind Pharma was the backer or acquirer, 2021–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

13 deals across Mankind Pharma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Mankind Pharma deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Mankind Pharma's portfolio, mapped.

        Stage
        Period
        13 of 13 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Mankind Pharma on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Mankind Pharma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles